State Bank of India vs Bristol-Myers Squibb Company
Market cap comparison over time
State Bank of India
$112.5B
Rank #142
Bristol-Myers Squibb Company
$116.2B
Rank #138
Market Cap Over Time
Year-by-Year Comparison
| Year | State Bank of India | Bristol-Myers Squibb Company | Leader |
|---|---|---|---|
| 2026 | $112.5B | $116.2B | Bristol-Myers Squibb Company |
| 2025 | $106.9B | $107.8B | Bristol-Myers Squibb Company |
| 2024 | $84.8B | $107.6B | Bristol-Myers Squibb Company |
| 2023 | $67.4B | $92.9B | Bristol-Myers Squibb Company |
| 2022 | $63.2B | $125.8B | Bristol-Myers Squibb Company |
| 2021 | $46.7B | $105.8B | Bristol-Myers Squibb Company |
| 2020 | $27.6B | $102.0B | Bristol-Myers Squibb Company |
| 2019 | $33.5B | $102.4B | Bristol-Myers Squibb Company |
| 2018 | $29.7B | $80.2B | Bristol-Myers Squibb Company |
| 2017 | $31.1B | $92.0B | Bristol-Myers Squibb Company |
| 2016 | $24.9B | $85.4B | Bristol-Myers Squibb Company |
| 2015 | $22.0B | $98.2B | Bristol-Myers Squibb Company |
| 2014 | $30.2B | $82.3B | Bristol-Myers Squibb Company |
| 2013 | $16.9B | $72.0B | Bristol-Myers Squibb Company |
| 2012 | $22.4B | $42.7B | Bristol-Myers Squibb Company |
| 2011 | $14.9B | $44.4B | Bristol-Myers Squibb Company |
| 2010 | $25.6B | $31.8B | Bristol-Myers Squibb Company |
| 2009 | $20.3B | $28.9B | Bristol-Myers Squibb Company |
| 2008 | $11.4B | $25.1B | Bristol-Myers Squibb Company |
| 2007 | $19.4B | $27.1B | Bristol-Myers Squibb Company |
| 2006 | $10.1B | $25.9B | Bristol-Myers Squibb Company |
| 2005 | $7.2B | $21.6B | Bristol-Myers Squibb Company |
| 2004 | $5.1B | $23.0B | Bristol-Myers Squibb Company |
| 2003 | $4.1B | $24.5B | Bristol-Myers Squibb Company |
| 2002 | $2.1B | $19.0B | Bristol-Myers Squibb Company |
| 2001 | $1.3B | $40.3B | Bristol-Myers Squibb Company |
| 2000 | $1.4B | $54.6B | Bristol-Myers Squibb Company |
| 1999 | $1.6B | $46.6B | Bristol-Myers Squibb Company |
| 1998 | $1.1B | $48.0B | Bristol-Myers Squibb Company |
| 1997 | $1.6B | $33.4B | Bristol-Myers Squibb Company |
| 1996 | $1.5B | $18.8B | Bristol-Myers Squibb Company |